MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration

    R. Bruffaerts, K. van Bouwel, PH. van Damme, K. Claeys, K. van Laere (Leuven, Belgium)

    Objective: We present a patient with a neurodegenerative disease where visuoperceptual testing led to a new working diagnosis of corticobasal degeneration (CBD) Background: CBD is a…
  • 2019 International Congress

    The cognitive profile associated with mild parkinsonian signs in a British Birth Cohort at age 69-71

    S. Buchanan, C. Lane, K. Lu, T. Parker, S. James, A. Keshavan, S. Keuss, H. Murray-Smith, A. Wong, D. Cash, W. Coath, S. Crutch, N. Fox, M. Richards, A. Schrag, J. Schott (London, United Kingdom)

    Objective: To test associations between mild parkinsonian signs (MPS), cognitive function and brain pathologies in Insight 46, a subsample of the MRC National Survey of…
  • 2019 International Congress

    Body Representation Impairments in Parkinson’s disease: A Preliminary Report

    J. Cardona, C. Martinez, W. Correa, J. Grisales, C. Trujillo, F. Marmolejo-Ramos (Santiago de Cali, Colombia)

    Objective: The current study investigates semantic processing (SP) and body representation (BR) in early Parkinson’s disease patients (ePDp) compared with neurologically healthy participants. Background: Although…
  • 2019 International Congress

    Semantic Memory Assessment in Parkinson’s Disease

    J. Cardona, F. Marmolejo-Ramos, C. Trujillo, M. Larson (Santiago de Cali, Colombia)

    Objective: We assessed the performance of patients with a diagnosis of Parkinson’s disease (PD) in a series of semantic memory (SM) tasks including both living…
  • 2019 International Congress

    Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

    G. Chandran (Mysore, India)

    Objective: To assess the non-inducing doses of scopolamine (SCL) on the memory function of Drosophila previously induced with Parkinson's disease phenotype. Background: A large body…
  • 2019 International Congress

    Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…
  • 2019 International Congress

    MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease

    SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee (Seoul, Republic of Korea)

    Objective: To investigate whether reversion to cognitively normal status (CogN) is clinically relevant in Parkinson’s disease with mild cognitive impairment (PD-MCI). Background: The concept of…
  • 2019 International Congress

    Cardiovascular autonomic function and MCI in Parkinson’s disease

    CE. Cicero, L. Raciti, R. Monastero, G. Mostile, G. Donzuso, G. Sciacca, A. Luca, C. Terravecchia, L. Giuliano, R. Baschi, M. Davì, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To evaluate the association between cardiovascular dysautonomia and Mild Cognitive Impairment (MCI) in Parkinson’s Disease (PD) patients. Background: Dysautonomic dysfunction and cognitive impairment represent…
  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • 2019 International Congress

    Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

    O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)

    Objective: We investigated neuroanatomical differences between Parkinson’s disease (PD) patients with and without semantic fluency impairment and explored predictive markers for dementia development. Background: Sematic…
  • « Previous Page
  • 1
  • …
  • 1346
  • 1347
  • 1348
  • 1349
  • 1350
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley